Innovative Stem Cell Technique Accelerates Creation of Microglia for Brain Research and Disease Modeling
Harvard researchers have developed a swift and efficient method to generate human microglia-like cells from stem cells, enabling advanced neurodegenerative disease research and therapeutic development.
A groundbreaking approach at Harvard University has enabled the rapid and efficient generation of human microglia-like cells from induced pluripotent stem cells (iPSCs). Microglia, vital immune cells in the brain accounting for about 10% of its cells, play essential roles in neuroinflammation, clearing debris, and supporting neural circuits. Dysfunction of microglia is linked to various neurodegenerative disorders such as Alzheimer's, Parkinson's, Huntington's disease, ALS, and multiple sclerosis.
Traditionally, obtaining human microglia is challenging due to the invasive biopsies required, and rodent microglia differ significantly from humans, complicating translational research. To overcome these hurdles, researchers at the Wyss Institute and Harvard Medical School led by George Church developed a novel system that reduces the differentiation process from 35 days to just four, saving time and resources.
This new method builds on the TFome™ platform, a comprehensive library of transcription factors (TFs) critical to cell fate determination. The team engineered TF libraries specific to microglia and screened different combinations to identify a potent six-TF cocktail capable of transforming iPSCs into microglia-like cells rapidly. These cells exhibited key genetic and functional similarities to primary human microglia, including responses to inflammatory stimuli and disease-related proteins like TDP-43.
Further refinement involved additional screening with a second set of TFs, resulting in a 6-TF cocktail that enhances microglia maturity and functionality. The cells demonstrated expected behavior when exposed to neuroinflammatory signals, such as interferon gamma, and pathogenic proteins associated with neurodegeneration, confirming their potential use in studying disease mechanisms.
The ability to produce microglia efficiently opens new avenues for brain disease research, drug discovery, and personalized medicine. This platform technology also holds promise for generating other difficult-to-isolate cell types, advancing the development of next-generation regenerative therapies. Overall, this innovation represents a significant step toward better understanding and treating neurological diseases.
Source: https://medicalxpress.com/news/2025-06-stem-cell-platform-aims-recreate.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Links Increased Hospital Acquisition of Private Practices to Rising Healthcare Costs
A groundbreaking study indicates that the rapid growth of hospital-owned private practices is driving up healthcare costs in the U.S., highlighting the need for regulatory scrutiny of mergers and acquisitions.
New Study Reveals How Brain Aging Is Driven by Protein Production Disruptions in Killifish
A groundbreaking study using turquoise killifish reveals that disruptions in protein synthesis, particularly translation elongation, are key to brain aging and neurodegeneration. Insights from this research could lead to new therapies targeting age-related cognitive decline.
High Prevalence of Sleep Disorders Uncovered in Yverdon-les-Bains Neighborhoods
A recent study in Yverdon-les-Bains reveals a high prevalence of sleep disorders among residents, highlighting significant public health concerns linked to urban environmental factors. Early detection and targeted interventions are crucial for improving sleep quality.
Research Reveals Fatty Liver Is Common in People with Type 2 Diabetes, But Severe Liver Damage Remains Rare
New research indicates that fatty liver disease is highly prevalent among individuals with type 2 diabetes, yet severe liver damage remains uncommon. Early detection and weight loss are key to prevention.